肺孢子菌肺外感染的临床表现和诊治研究进展

摘要/Abstract

摘要： 肺孢子菌肺炎（Pneumocystis pneumonia，PCP）是HIV患者最常见的机会性感染，临床上肺外组织肺孢子菌感染少见且容易误诊，多为个案报道。本文通过文献检索和分析，总结宿主肺外感染肺孢子菌的临床表现及诊治结果。结果表明肺外孢子菌感染的临床表现多不典型，但可以累及单个或多个系统，PCR技术及宏基因检测可有助于早期诊断并提高重症患者救治的成功率。治疗上仍以复方磺胺甲噁唑治疗为首选，尽早识别肺孢子菌肺外感染和提高多系统受累患者的救治受到临床关注。

关键词: 肺孢子菌, 肺外感染, 诊断, 治疗

中图分类号:

R519.8

梁毅, 申颖. 肺孢子菌肺外感染的临床表现和诊治研究进展[J]. 中国真菌学杂志, 2022, 17(2): 163-167.

参考文献

[1] MAINI R, HENDERSON K L, SHERIDAN E A, et al. Increasing pneumocystis pneumonia, England, UK, 2000-2010[J]. Emerg Infect Dis, 2013, 19(3):386-392.
[2] AVINO L J, NAYLOR S M, ROECKER A M. Pneumocystis jirovecii pneumonia in the non-HIV-infected population[J]. Ann Pharmacother, 2016, 50(8):673-679.
[3] YU Q, JIA P, SU L, et al. Outcomes and prognostic factors of non-HIV patients with Pneumocystis jirovecii pneumonia and pulmonary CMV co-infection:A retrospective cohort study[J]. BMC Infect Dis, 2017, 17(1):392.
[4] NG V L, YAJKO D M, HADLEY W K.Extrapulmonary pneumocystosis[J]. Clin Microbiol Rev, 1997, 10(3):401-418.
[5] COHEN O J, STOECKLE M Y.Extrapulmonary Pneumocystis carinii infections in the acquired immunodeficiency syndrome[J]. Arch Intern Med, 1991, 151(6):1205-1214.
[6] RAVIGLIONE M C.Extrapulmonary pneumocystosis:the first 50 cases[J]. Rev Infect Dis, 1990, 12(6):1127-1138.
[7] COTE R J, ROSENBLUM M, TELZAK EE, et al. Disseminated Pneumocystis carinii infection causing extrapulmonary organ failure:clinical, pathologic, and immunohistochemical analysis[J]. Mod Pathol, 1990, 3(1):25-30.
[8] SHARMA N, AHLAWAT R S, SINGH H, et al.Pneumocystis jirovecii infection of bilateral adrenal glands in an immunocompetent adult:a case report[J]. J R Coll Physicians Edinb, 2019, 49(3):222-224.
[9] VALDEBENITO C, BONACIC M, MATAMALA J, et al.Extrapulmonary pneumocystosis:a case report[J]. Rev Chilena Infectol, 2015, 32(3):344-349.
[10] KARAM M B, MOSADEGH L. Extra-pulmonary Pneumocystis jiroveci infection:a case report[J]. Braz J Infect Dis, 2014, 18(6):681-685.
[11] PANOS G Z, KARYDIS I, VELAKOULIS S E, et al. Multi-skeletal Pneumocystis jiroveci(carinii) in an HIV-seropositive patient[J]. Int J STD AIDS, 2007, 18(2):134-137.
[12] TAN G D, SHAW P J, MILLER R F. Granulomatous extrapulmonary pneumocystosis[J]. Int J STD AIDS, 1998, 9(2):111-113.
[13] SUNDAR K, ROSADO-SANTOS H, REIMER L, et al. Unusual presentation of thoracic Pneumocystis carinii infection in a patient with acquired immunodeficiency syndrome[J]. Clin Infect Dis, 2001, 32(3):498-501.
[14] ANURADHA, SINHA A.Extrapulmonary Pneumocystis carinii infection in an AIDS patient:a case report[J]. Acta Cytol, 2007, 51(4):599-601.
[15] ZAMUCO R L, YANG G C. Clue to fine-needle aspiration diagnosis of pleural pneumocystoma:neovascularization and Langhans' giant cell reaction[J]. Diagn Cytopathol, 2005, 33(2):97-99.
[16] KIM B, KIM J, PAIK SS, et al. Atypical presentation of Pneumocystis jirovecii infection in HIV infected patients:three different manifestations[J]. J Korean Med Sci, 2018, 33(15):e115.
[17] RIGHI E, LA ROSA A, SARTOR A, et al. Persisten thematogenous dissemination in pulmonary P. jiroveci infection[J]. Mycopathologia, 2019, 184(3):457-458.
[18] LAGROU K, CHEN S, MASUR H, et al. Pneumocystis jirovecii disease:basis for the revised EORTC/MSGERC invasive fungal disease definitions in individuals without human immunodeficiency vius[J]. Clin Infect Dis, 2021, 72(Suppl 2):S114-s120.
[19] SCHILDGEN V, MAI S, KHALFAOUI S, et al.Pneumocystis jirovecii can be productively cultured in differentiated CuFi-8 airway cells[J]. mBio, 2014, 5(3):e01186-14.
[20] BATEMAN M, OLADELE R, KOLLS J K. Diagnosing Pneumocystis jirovecii pneumonia:A review of current methods and novel approaches[J]. Med Mycol, 2020, 58(8):1015-1028.
[21] SENéCAL J, SMYTH E, DEL CORPO O, et al. Non-invasive diagnosis of Pneumocystis jirovecii pneumonia:a systematic review and meta-analysis[J]. Clin Microbiol Infect, 2022,28(1):23-30.
[22] CORDONNIER C, CESARO S,MASCHMEYER G, et al. Pneumocystis jirovecii pneumonia:still a concern in patients with haematological malignancies and stem cell transplant recipients[J]. J Antimicrob Chemother, 2016, 71(9):2379-2385.
[23] WANG H W, LIN C C, KUO C F, et al. Mortality predictors of Pneumocystis jirovecii pneumonia in human immunodeficiency virus-infected patients at presentation:Experience in a tertiary care hospital of northern Taiwan[J]. J Microbiol Immunol Infect, 2011, 44(4):274-281.
[24] VOGEL M, WEISSGERBER P, GOEPPERT B, et al. Accuracy of serum LDH elevation for the diagnosis of Pneumocystis jiroveci pneumonia[J]. Swiss Med Wkly, 2011, 141 w13184.
[25] WHITE P L, BACKX M, BARNES R A. Diagnosis and management of Pneumocystis jirovecii infection[J]. Expert Rev Anti Infect Ther, 2017, 15(5):435-447.
[26] DAMIANI C, LE GAL S, DA COSTA C, et al. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum(1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization[J]. J Clin Microbiol, 2013, 51(10):3380-3388.
[27] MARTíNEZ LAMAS L, PéREZ RODRíGUEZ M T, ÁLVAREZ RAMOS I, et al. Role of Pneumocystis jirovecii in patients with different pulmonary underlying condition using a nested-PCR[J]. Rev Esp Quimioter, 2018, 31(4):336-343.
[28] SANTOS C R, DE ASSIS Â M, LUZ E A, et al. Detection of Pneumocystis jirovecii by nested PCR in HIV-negative patients with pulmonary disease[J]. Rev Iberoam Micol, 2017, 34(2):83-88.
[29] 王瑜琼, 黄琳娜, 詹庆元. 肺孢子菌肺炎诊断方法的研究进展[J]. 中华结核和呼吸杂志, 2020, 43(10):878-880.
[30] FRéALLE E, GANTOIS N, ALIOUAT-DENIS C M, et al. Comparison of different blood compartments for the detection of circulating DNA using a rat model of Pneumocytis pneumonia[J]. Med Mycol, 2015, 53(7):754-759.
[31] 张为, 佘丹阳, 谢晓玮,等. 二代测序技术在非人类免疫缺陷病毒感染者肺孢子菌肺炎诊断中的应用价值[J]. 中华结核和呼吸杂志, 2020, 43(10):844-849.
[32] KONO M, YAMASHITA H, KUBOTA K, et al. FDG-PET imaging in Pneumocystis pneumonia[J]. Clin Nucl Med, 2015, 40(8):679-681.
[33] LECUIT M, LIVARTOWSKI J, VONS C, et al. Resistance to trimethoprim-sulfamethoxazole and sensitivity to pentamidine therapy in an AIDS patient with hepatosplenic pneumocytosis[J]. Aids, 1994, 8(10):1506-1507.
[34] MONTESINOS I, DELFORGE M L, AJJAHAM F,et al. Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase(DHPS) mutations[J]. Diagn Microbiol Infect Dis, 2017, 87(1):32-36.
[35] PONCE C A,CHABé M, GEORGE C, et al. High prevalence of Pneumocystis jirovecii dihydropteroate synthase gene mutations in patients with a first episode of Pneumocystis pneumonia in Santiago, Chile, and clinical response to trimethoprim-sulfamethoxazole therapy[J]. Antimicrob Agents Chemother, 2017, 61(2):e01290-16.
[36] SUK C W, BAI K J, YU M C, et al.Coinfection of Pneumocystis jiroveci pneumonia and pulmonary tuberculosis in a non-HIV-infected patient[J]. J Microbiol Immunol Infect, 2015, 48(6):711-712.
[36] CUSHION M T, COLLINS M S. Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures[J]. Antimicrob Agents Chemother, 2011, 55(10):4513-4518.